黏菌素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "黏菌素" in Chinese language version.

refsWebsite

Global rank Chinese rank

26nih.gov

4^th place

5^th place

24doi.org

2^nd place

23^rd place

8web.archive.org

1^st place

6semanticscholar.org

11^th place

332^nd place

3medicines.org.uk

3,823^rd place

3,456^th place

2drugs.com

399^th place

208^th place

2handle.net

102^nd place

492^nd place

2toku-e.com

low place

1canada.ca

1,712^th place

3,316^th place

1europa.eu

68^th place

209^th place

1books.google.com

3^rd place

8^th place

1wikiwix.com

194^th place

1,077^th place

1theatlantic.com

228^th place

597^th place

1nationalgeographic.com

344^th place

408^th place

1sciencedaily.com

993^rd place

1,142^nd place

1journalindex.net

low place

1indiatimes.com

17^th place

397^th place

1cdc.gov

218^th place

198^th place

1wsj.com

79^th place

143^rd place

1uptodate.com

3,771^st place

4,225^th place

1nature.com

234^th place

227^th place

books.google.com

Bennett JE, Dolin R, Blaser MJ, Mandell GL. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book. Elsevier Health Sciences. 2009: 469. ISBN 9781437720600.

canada.ca

health-products.canada.ca

Drug Product Database. Health Canada. 2012-04-25 [2022-01-13].

cdc.gov

Discovery of first mcr-1 gene in E. coli bacteria found in a human in United States. cdc.gov. U.S. Department of Health and Human Services. 2016-05-31 [2016-07-06]. （原始内容存档于2016-07-11）.

doi.org

Pogue JM, Ortwine JK, Kaye KS. Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing. Clinical Microbiology and Infection. April 2017, 23 (4): 229–233. PMID 28238870. doi:10.1016/j.cmi.2017.02.023 .
Falagas ME, Grammatikos AP, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Review of Anti-Infective Therapy. October 2008, 6 (5): 593–600. PMID 18847400. S2CID 13158593. doi:10.1586/14787210.6.5.593.
Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. June 2006, 50 (6): 1953–1958. PMC 1479097 . PMID 16723551. doi:10.1128/AAC.00035-06.
Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveillance. 2015-12-10, 20 (49): 30085. PMID 26676364. doi:10.2807/1560-7917.ES.2015.20.49.30085 .
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet. Infectious Diseases. September 2006, 6 (9): 589–601. PMID 16931410. doi:10.1016/s1473-3099(06)70580-1.
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet. Infectious Diseases. February 2016, 16 (2): 161–168. PMID 26603172. doi:10.1016/S1473-3099(15)00424-7.
Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Current Medical Research and Opinion. April 2015, 31 (4): 707–721. PMID 25697677. S2CID 33476061. doi:10.1185/03007995.2015.1018989 .
El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clinical Microbiology Reviews. January 2015, 28 (1): 191–207. PMC 4284305 . PMID 25567227. doi:10.1128/CMR.00058-14.
Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS. Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection. mBio. March 2018, 9 (2): e02448–17. PMC 5844991 . PMID 29511071. doi:10.1128/mBio.02448-17.
Wolinsky E, Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. The New England Journal of Medicine. April 1962, 266 (15): 759–762. PMID 14008070. doi:10.1056/NEJM196204122661505.
Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Annals of Internal Medicine. June 1970, 72 (6): 857–868. PMID 5448745. doi:10.7326/0003-4819-72-6-857.
Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ. Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. The European Respiratory Journal. September 1998, 12 (3): 592–594. PMID 9762785. doi:10.1183/09031936.98.12030592 .
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents. January 2005, 25 (1): 11–25. PMID 15620821. doi:10.1016/j.ijantimicag.2004.10.001.
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. The Annals of Pharmacotherapy. November 2000, 34 (11): 1238–1242. PMID 11098334. S2CID 42625124. doi:10.1345/aph.19370.
Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP, et al. A ten year review of colomycin. Respiratory Medicine. July 2000, 94 (7): 632–640. PMID 10926333. doi:10.1053/rmed.2000.0834 .
Stein A, Raoult D. Colistin: an antimicrobial for the 21st century?. Clinical Infectious Diseases. October 2002, 35 (7): 901–902. PMID 12228836. doi:10.1086/342570 .
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Maddison J, Dodd M, Webb AK. Nebulized colistin causes chest tightness in adults with cystic fibrosis. Respiratory Medicine. February 1994, 88 (2): 145–147. PMID 8146414. doi:10.1016/0954-6111(94)90028-0 .
Kamin W, Schwabe A, Krämer I. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. Journal of Cystic Fibrosis. December 2006, 5 (4): 205–213. PMID 16678502. doi:10.1016/j.jcf.2006.03.007 .
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet. Infectious Diseases. September 2006, 6 (9): 589–601. PMID 16931410. doi:10.1016/S1473-3099(06)70580-1.
Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. The Journal of Antimicrobial Chemotherapy. May 2004, 53 (5): 837–840. PMID 15044428. doi:10.1093/jac/dkh167 .
Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrobial Agents and Chemotherapy. May 2003, 47 (5): 1766–1770. PMC 153303 . PMID 12709357. doi:10.1128/AAC.47.5.1766-1770.2003.
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clinical Infectious Diseases. May 2005, 40 (9): 1333–1341. PMID 15825037. S2CID 21679015. doi:10.1086/429323 .

drugs.com

Colistimethate Sodium Monograph for Professionals. Drugs.com. [2019-11-06].
Colistimethate (Coly Mycin M) Use During Pregnancy. Drugs.com. [2019-11-11].

europa.eu

ema.europa.eu

Colobreathe EPAR. European Medicines Agency. 2018-09-17 [12020-11-16].

handle.net

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization. Critically important antimicrobials for human medicine 6th revision. Geneva: World Health Organization. 2019. ISBN 9789241515528. hdl:10665/312266 .

indiatimes.com

timesofindia.indiatimes.com

New worry: Resistance to 'last antibiotic' surfaces in India. The Times of India. 2014-12-28. （原始内容存档于2014-12-31）.

journalindex.net

Emergence of Pan drug resistance amongst gram negative bacteria! The First case series from India. December 2014.

medicines.org.uk

Colobreathe 1,662,500 IU inhalation powder, Hard Capsules – Summary of Product Characteristics (SmPC). (emc). [2020-11-16].
Colomycin 1 million International Units (IU) Powder for solution for injection, infusion or inhalation – Summary of Product Characteristics (SmPC). (emc). 2020-05-27 [16 November 2020].
Promixin 1 million International Units (IU) Powder for Nebuliser Solution – Summary of Product Characteristics (SmPC). (emc). 2020-09-23 [2020-11-16].

nationalgeographic.com

phenomena.nationalgeographic.com

McKenna M. Apocalypse Pig Redux: Last-Resort Resistance in Europe. Phenomena. 2015-12-03 [2016-05-28]. （原始内容存档于2016-05-28）.

nature.com

Schoenmakers K. How China is getting its farmers to kick their antibiotics habit. Nature. 2020-10-21 [2021-08-02].

nih.gov

ncbi.nlm.nih.gov

Pogue JM, Ortwine JK, Kaye KS. Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing. Clinical Microbiology and Infection. April 2017, 23 (4): 229–233. PMID 28238870. doi:10.1016/j.cmi.2017.02.023 .
Falagas ME, Grammatikos AP, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Review of Anti-Infective Therapy. October 2008, 6 (5): 593–600. PMID 18847400. S2CID 13158593. doi:10.1586/14787210.6.5.593.
Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. June 2006, 50 (6): 1953–1958. PMC 1479097 . PMID 16723551. doi:10.1128/AAC.00035-06.
Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveillance. 2015-12-10, 20 (49): 30085. PMID 26676364. doi:10.2807/1560-7917.ES.2015.20.49.30085 .
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet. Infectious Diseases. September 2006, 6 (9): 589–601. PMID 16931410. doi:10.1016/s1473-3099(06)70580-1.
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet. Infectious Diseases. February 2016, 16 (2): 161–168. PMID 26603172. doi:10.1016/S1473-3099(15)00424-7.
Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Current Medical Research and Opinion. April 2015, 31 (4): 707–721. PMID 25697677. S2CID 33476061. doi:10.1185/03007995.2015.1018989 .
El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clinical Microbiology Reviews. January 2015, 28 (1): 191–207. PMC 4284305 . PMID 25567227. doi:10.1128/CMR.00058-14.
Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS. Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection. mBio. March 2018, 9 (2): e02448–17. PMC 5844991 . PMID 29511071. doi:10.1128/mBio.02448-17.
Wolinsky E, Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. The New England Journal of Medicine. April 1962, 266 (15): 759–762. PMID 14008070. doi:10.1056/NEJM196204122661505.
Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Annals of Internal Medicine. June 1970, 72 (6): 857–868. PMID 5448745. doi:10.7326/0003-4819-72-6-857.
Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ. Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. The European Respiratory Journal. September 1998, 12 (3): 592–594. PMID 9762785. doi:10.1183/09031936.98.12030592 .
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents. January 2005, 25 (1): 11–25. PMID 15620821. doi:10.1016/j.ijantimicag.2004.10.001.
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. The Annals of Pharmacotherapy. November 2000, 34 (11): 1238–1242. PMID 11098334. S2CID 42625124. doi:10.1345/aph.19370.
Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP, et al. A ten year review of colomycin. Respiratory Medicine. July 2000, 94 (7): 632–640. PMID 10926333. doi:10.1053/rmed.2000.0834 .
Stein A, Raoult D. Colistin: an antimicrobial for the 21st century?. Clinical Infectious Diseases. October 2002, 35 (7): 901–902. PMID 12228836. doi:10.1086/342570 .
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Maddison J, Dodd M, Webb AK. Nebulized colistin causes chest tightness in adults with cystic fibrosis. Respiratory Medicine. February 1994, 88 (2): 145–147. PMID 8146414. doi:10.1016/0954-6111(94)90028-0 .
Kamin W, Schwabe A, Krämer I. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. Journal of Cystic Fibrosis. December 2006, 5 (4): 205–213. PMID 16678502. doi:10.1016/j.jcf.2006.03.007 .
Domínguez-Ortega J, Manteiga E, Abad-Schilling C, Juretzcke MA, Sánchez-Rubio J, Kindelan C. Induced tolerance to nebulized colistin after severe reaction to the drug. Journal of Investigational Allergology & Clinical Immunology. 2007, 17 (1): 59–61. PMID 17323867.
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet. Infectious Diseases. September 2006, 6 (9): 589–601. PMID 16931410. doi:10.1016/S1473-3099(06)70580-1.
Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. The Journal of Antimicrobial Chemotherapy. May 2004, 53 (5): 837–840. PMID 15044428. doi:10.1093/jac/dkh167 .
Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrobial Agents and Chemotherapy. May 2003, 47 (5): 1766–1770. PMC 153303 . PMID 12709357. doi:10.1128/AAC.47.5.1766-1770.2003.
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clinical Infectious Diseases. May 2005, 40 (9): 1333–1341. PMID 15825037. S2CID 21679015. doi:10.1086/429323 .

dailymed.nlm.nih.gov

Coly-Mycin M- colistimethate injection. DailyMed. 3 December 2018 [2020-11-16].

sciencedaily.com

First discovery in United States of colistin resistance in a human E. coli infection. www.sciencedaily.com. [2016-05-27]. （原始内容存档于2016-05-27）.

semanticscholar.org

api.semanticscholar.org

Falagas ME, Grammatikos AP, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Review of Anti-Infective Therapy. October 2008, 6 (5): 593–600. PMID 18847400. S2CID 13158593. doi:10.1586/14787210.6.5.593.
Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Current Medical Research and Opinion. April 2015, 31 (4): 707–721. PMID 25697677. S2CID 33476061. doi:10.1185/03007995.2015.1018989 .
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. The Annals of Pharmacotherapy. November 2000, 34 (11): 1238–1242. PMID 11098334. S2CID 42625124. doi:10.1345/aph.19370.
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. November 2001, 7 (6): 434–440. PMID 11706322. S2CID 38084953. doi:10.1097/00063198-200111000-00013.
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clinical Infectious Diseases. May 2005, 40 (9): 1333–1341. PMID 15825037. S2CID 21679015. doi:10.1086/429323 .

theatlantic.com

Zhang S. Resistance to the Antibiotic of Last Resort Is Silently Spreading. The Atlantic. [2017-01-12]. （原始内容存档于2017-01-13）.

toku-e.com

antibiotics.toku-e.com

Polymyxin E (Colistin) – The Antimicrobial Index Knowledgebase – TOKU-E. [2016-05-25]. （原始内容存档于2016-05-28）.

toku-e.com

Colistin sulfate, USP Susceptibility and Minimum Inhibitory Concentration (MIC) Data (PDF). 2016-03-03 [2014-02-10]. （原始内容存档 (PDF)于2016-03-04）.

uptodate.com

MacLaren G, Spelman D. Hopper DC, Hall KK , 编. Colistin: An overview. UpToDate. Wolters Kluwer. 2022-11-22 [2016-06-06]. （原始内容存档于2016-05-31）.

web.archive.org

Colistin sulfate, USP Susceptibility and Minimum Inhibitory Concentration (MIC) Data (PDF). 2016-03-03 [2014-02-10]. （原始内容存档 (PDF)于2016-03-04）.
Zhang S. Resistance to the Antibiotic of Last Resort Is Silently Spreading. The Atlantic. [2017-01-12]. （原始内容存档于2017-01-13）.
McKenna M. Apocalypse Pig Redux: Last-Resort Resistance in Europe. Phenomena. 2015-12-03 [2016-05-28]. （原始内容存档于2016-05-28）.
First discovery in United States of colistin resistance in a human E. coli infection. www.sciencedaily.com. [2016-05-27]. （原始内容存档于2016-05-27）.
New worry: Resistance to 'last antibiotic' surfaces in India. The Times of India. 2014-12-28. （原始内容存档于2014-12-31）.
Discovery of first mcr-1 gene in E. coli bacteria found in a human in United States. cdc.gov. U.S. Department of Health and Human Services. 2016-05-31 [2016-07-06]. （原始内容存档于2016-07-11）.
McKay B. Common 'Superbug' Found to Disguise Resistance to Potent Antibiotic. wsj.com. Wall Street Journal. 2018-03-06 [2018-11-01]. （原始内容存档于2018-04-03）.
MacLaren G, Spelman D. Hopper DC, Hall KK , 编. Colistin: An overview. UpToDate. Wolters Kluwer. 2022-11-22 [2016-06-06]. （原始内容存档于2016-05-31）.

wikiwix.com

archive.wikiwix.com

Polymyxin E (Colistin) – The Antimicrobial Index Knowledgebase – TOKU-E. [2016-05-25]. （原始内容存档于2016-05-28）.

wsj.com

McKay B. Common 'Superbug' Found to Disguise Resistance to Potent Antibiotic. wsj.com. Wall Street Journal. 2018-03-06 [2018-11-01]. （原始内容存档于2018-04-03）.